ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
China Launches New Probe into Pharma Corruption; Novartis Accused of Bribery
publication date: Aug 14, 2013
On Thursday, China’s State Administration for Industry and Commerce (SAIC) will begin a new three-month investigation to root out bribery in China’s pharmaceutical and medical services industries. The announcement came as a former drug salesperson charged that Novartis paid doctors to prescribe its products. More details....
Stock Symbol: (NYSE: NVS)
Share this with colleagues:
This article is available for purchase - please click here for details.
Sorry this page is available to subscribers only. If you're not a subscriber why not subscribe today?